Triamcinolone acetonide injectable suspension for suprachoroidal use in the treatment of macular edema associated with uveitis.

ABSTRACT:

Introduction

Macular edema due to noninfectious uveitis is a sight-threatening complication that is routinely treated with corticosteroids. Triamcinolone acetonide injectable suspension for suprachoroidal use (Xipere^™) is an alternative treatment option for patients with non-infectious uveitis associated macular edema.

Areas covered

This review describes the recently FDA approved triamcinolone acetonide injectable suspension that can be injected into the suprachoroidal space. This physiological space is between the sclera and choroid. This allows for therapeutic targeting of the retina and choroid. This review highlights published clinical trials for this novel drug preparation.

Expert opinion

Suprachoroidal administration of triamcinolone acetonide has sho

SUBMITTER: Thomas J 

PROVIDER: S-EPMC9438525 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature